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Expression of a transfected MyoD gene induces myogenic differentiation of most cell types. In this study, we evaluated
the ability of an exogenous MyoD gene to induce myogenic conversion in two pairs of matched cell lines with different
degrees of differentiation within either the osteoblastic or chondrocytic lineage. We show that osteoblasts and chondrocytes
are resistant to the myogenic effects of MyoD alone. However, in their less-differentiated cell line counterparts, MyoD
induces expression of muscle-cell-speci®c markers. Less-differentiated osteoblasts can be made resistant to MyoD-induced
myogenic conversion by induction of adipogenic differentiation using dexamethasone. Finally, a dominant positive form
of MyoD, one which is tethered to a partner, E47, activates muscle-speci®c gene expression in osteoblasts. Our results
suggest that the response of a cell to MyoD depends on its lineage and its degree of differentiation. Furthermore, commit-
ment of cells to the osteoblastic or chondrocytic lineage may involve inhibition of alternative pathways, such as those
leading to myoblastic differentiation. Finally, osteoblasts may express a protein(s) which interferes with the activity of
MyoD by inhibiting its association with E proteins. This interference can be overcome by expression of the MyoD±E47
hybrid, suggesting that osteoblasts are otherwise competent to undergo myogenic conversion. q 1996 Academic Press, Inc.
INTRODUCTION lineages (Davis et al., 1987; Weintraub et al., 1989; Choi et
al., 1990; Boukamp et al., 1992). For this reason, MyoD
During development, the differentiation potential of cells has been called a ``master regulatory gene'' for myogenesis
becomes gradually restricted as they become committed to (Weintraub et al., 1989). MyoD activates transcription of
a de®ned lineage. Skeletal muscle cells are an excellent muscle-speci®c genes by associating with a member of a
system to study the process of commitment, since their family of ubiquitous bHLH proteins, called E proteins
differentiation program involves distinct, well-character- (Murre et al., 1989a,b; reviewed in Kadesch, 1992), and bind-
ized morphological and biochemical changes. Early studies ing to de®ned sequences, called E boxes, upstream from
of heterokaryons showed that muscle cells express proteins these genes (Ephrussi et al., 1985; Church et al., 1985). The
capable of activating muscle-speci®c genes in other cell fact that MyoD can convert most cell types to a myogenic
types (Blau et al., 1983). Subsequent studies led to the iden- phenotype suggests that no other tissue-speci®c proteins are
ti®cation of the genes for MyoD (Davis et al., 1987) and required for MyoD activity (Weintraub et al., 1989). Rather,
several related, muscle-speci®c transcription factors (re- MyoD activity can be regulated by ubiquitous proteins,
viewed in Edmondson and Olson, 1993) which can induce some of which may also function in growth control or in
myogenic differentiation in vitro (reviewed in Olson, 1990; other differentiation processes. For example, expression of
and Weintraub et al., 1991) and in vivo (Hopwood et al., the ubiquitous transcription factor pRB, which plays a key
1991; Miner et al., 1992). In addition, members of this fam- role in regulation of the cell cycle, is required for MyoD
ily of basic helix±loop±helix (bHLH) proteins can activate activity (Gu et al., 1993). Furthermore, some tumors or tu-
their own, as well as each other's, expression in transfected mor-derived cell lines, which exhibit uncontrolled growth
cells, which may be important for the maintenance of the and lose expression of their intrinsic differentiation pro-
myogenic phenotype (Braun et al., 1989; Thayer et al., 1989; gram, are resistant to MyoD-induced differentiation (Wein-
Edmondson et al., 1991). traub et al., 1989; Dias et al., 1992; Tapscott et al., 1993).
Forced expression of MyoD can induce expression of mus- Finally, other tissue-speci®c bHLH proteins, such as SCL/
TAL and MASH, also heterodimerize with the same E pro-cle-speci®c proteins in cells derived from many different
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teins as MyoD, suggesting that the ubiquitous E proteins observations, as well as on the temporal expression pattern
of markers in primary cultures in vitro, certain cell linesare involved in hematopoietic and neural cell differentia-
tion (Hsu et al., 1991; Johnson et al., 1992) as well as in may be ``more mature'' than others due to their expression
of speci®c proteins. For our studies, we have used two pairsmyogenic differentiation.
For cells of mesenchymal origin, expression of a myogenic of closely related cell lines, one pair to represent osteoblas-
tic cells and the other as characteristic of chondrocytic cells.phenotype is correlated with a loss of expression of the
intrinsic differentiation program and vice versa. For exam- Both cell lines within each pair were derived at the same
time from the same tissue and differentially express speci®cple, adipocyte cell lines transfected with MyoD yield colo-
nies of either muscle or fat cells, but not cells expressing markers. As such, these cell lines may represent different
stages of progression along their respective pathways, i.e.,both fat and muscle markers (Weintraub et al., 1989). Simi-
larly, myoblasts treated with thiazolidinediones or fatty osteoblastic or chondrogenic. For this reason, we refer to
cells which express little, if any, of the early differentiationacids (Teboul et al., 1995) or transfected with adipogenic
transcription factors (Hu et al., 1995) lose their ability to markers and none of the later ones as ``less differentiated.''
Those cells which express high levels of early markers, anddifferentiate into myotubes and gain the ability to differen-
tiate into mature adipocytes. In addition, treatment of myo- may express later ones as well, are considered to be ``more
differentiated.'' Our studies show that, in both the osteo-blasts (Katagiri et al., 1994) or pluripotential cells (Yama-
guchi et al., 1991) with bone morphogenetic protein-2 blastic and chondrocytic lineages, only the less-differenti-
ated cells can undergo myogenic differentiation after ex-(BMP-2) induces expression of osteoblastic markers and in-
hibits myogenic differentiation. Finally, expression of pression of an exogenous MyoD gene. These results suggest
that the ability of a cell to respond to MyoD is determinedMyoD in chondroblasts leads to loss of expression of carti-
lage-speci®c markers (Choi et al., 1990). This apparent mu- by its intrinsic differentiation state. However, the more dif-
ferentiated osteoblastic cells could be induced to expresstual exclusivity of myogenic differentiation with adipo-
genic, osteoblastic, or chondrocytic differentiation suggests a myogenic phenotype by transfection with a ``dominant
positive'' version of MyoD, in which MyoD is tethered tothat these processes may compete for a limited amount of
de®ned cellular protein(s). In contrast, in cells from other, E47 (Neuhold and Wold, 1993), suggesting that these cells
are otherwise competent to undergo myogenic conversion.nonmesenchymal origins, such as epithelial (Boukamp et
al., 1992) and neural crest cells (Weintraub et al., 1989), Thus, our data support the hypothesis that, for cells which
are close in lineage to myoblasts, the ability to undergothe myogenic phenotype can exist in conjunction with the
endogenous differentiation program. Thus, the differentia- MyoD-induced myogenesis is lost as cells become more
differentiated along an alternative pathway.tion response of cells to MyoD may depend on their lineage
``history'' (Schafer et al., 1990). Consequently, cells which
are close in lineage to muscle, such as those of mesenchy-
mal origin, may require a mechanism(s) which leads to mu- MATERIALS AND METHODS
tual exclusivity of differentiation programs and protects
against myogenic conversion in case of aberrant MyoD ex- Cell Culture and Transfections and Infections
pression. In contrast, more distantly related cell types, such
as epithelial cells, might not have such a mechanism. Fur- ROB C20 and C26 cells, originally puri®ed by limited dilution
subcloning of cells migrating from explants of parietal bones of 1-thermore, the ability of a cell to undergo MyoD-induced
day-old rats (Yamaguchi and Kahn, 1991), were obtained from Dr.myogenic conversion might be used as a diagnostic measure
A. Kahn and grown in 10% fetal calf serum (FCS) in DMEawithoutto evaluate whether a mesenchymal cell is committed to a
nucleosides. RCJ3.1 C12 and C5.18, which were subcloned by lim-particular lineage, and may provide insight into the mecha-
iting dilution of cells from sequential collagenase digestion of 21-nistic basis of such commitment.
day fetal rat calvariae (Grigoriadis et al., 1988, 1990), were obtained
To further understand the process of commitment, we from Dr. J. Aubin and grown in 15% fetal calf serum (FCS) in DMEa
tested whether expression of MyoD has the ability to induce with nucleosides, in the presence or absence of dexamethasone
myogenic differentiation of well-characterized mesenchy- (1007 M). C2C12 cells (Yaffe and Saxel, 1977; Blau et al., 1983)
mal cell lines. In addition to adipogenic or myogenic pheno- were obtained from Dr. Helen Blau and were grown in 20% FCS
in DMEM. To induce myogenic differentiation, parental and trans-types, mesenchymal stem cells can be induced to express
fected or infected cells were switched into differentiation mediaproteins found in osteoblastic or chondrocytic cells (Taylor
consisting of DMEM with 2% horse serum or DMEM with insulin,and Jones, 1979; Yamaguchi and Kahn, 1991; Grigoriadis et
transferrin, and selenium (GMS-G, Gibco, BRL) for 3 to 5 days.al., 1988, 1990). Although the sequence of expression of
Using the calcium phosphate precipitation method (Sambrook,some of these markers is not yet known, speci®c proteins,
1989), C20 cells were stably transfected with MyoD (Davis et al.,such as osteocalcin, found in osteoblasts within bone, and
1987) subcloned into an expression vector containing the CMV
collagen X, found in chondrocytes within hypertrophic car- promoter and encoding neomycin resistance (pcDNAINeo, In-
tilage, are considered to be markers of more mature cells. Vitrogen). In subsequent experiments, C20 cells were stably co-
Other proteins, such as alkaline phosphatase and collagen transfected with plasmids encoding neomycin resistance and with
II, are expressed in areas of bone and cartilage, respectively, vectors containing the SV40 promoter driving expression of MyoD
alone, E47 alone, or the MyoD±E47-tethered protein (Neuhold andwhich contain less mature cells. Based on these in vivo
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Wold, 1993). The transfected cells were then cultured in medium al., 1988) were purchased from Pharmingen. MyoD antibodies were
kindly provided by Dr. Peter Dias and Dr. Peter Houghton (Dias etcontaining G418 (400 mg/ml). After 14 to 21 days, G418-resistant
clones were isolated and expanded, and the MyoD-transfected cells al., 1992), and those for myogenin were received from Dr. Woodring
Wright (Southwestern Medical School, Dallas, TX).were screened by Northern hybridization for expression of mRNA
for MyoD. Colonies of the C20 cells transfected with the MyoD±
E47 construct were immediately subcloned and screened for myo-
genic conversion since expression of this construct would be ex-
Immuno¯uorescencepected to inhibit growth (Sorrentino et al., 1990) and in other cell
lines, stable clones could not be obtained (Neuhold and Wold,
Cells grown on coverslips were washed three times with phos-1993).
phate-buffered saline (PBS) and ®xed in methanol (for myosin heavyFor retroviral infections, we used a high-titer MyoD retrovirus
chain or collagen II antibodies) or in 4% formaldehyde in PBS (forwhich was kindly supplied by Dr. Dusty Miller (Weintraub et al.,
MyoD) for 10 min at room temperature. After washing with PBS,1989). Similar results were obtained following infection with a
cells were incubated in 0.1% Triton in PBS for 10 min and rinsedlower titer virus encoding MyoD and hygromycin resistance (Lassar
again with PBS. The samples were then treated with 3% bovineet al., 1989a). Viral infections were performed by incubating grow-
serum albumin (BSA) in PBS for 15±30 min, and incubated withing cells overnight with viral stock plus 4 mg/ml of polybrene. Two
primary antibody for 45 min at 377C. After three washes in PBS,days after infection, cells were switched to medium containing
the cells were incubated with secondary antibodies (Jackson Immu-either G418 (400 mg/ml) for the high-titer virus or hygromycin (500
noResearch, West Grove, PA) which were either rhodamine-conju-mg/ml) for the lower-titer virus, to select for infected cells.
gated (for myosin heavy chain and MyoD antibodies) or ¯uorescein-Treatment of C26 cells with dexamethasone (1007 M) and assess-
conjugated (for collagen II antibodies) for 45 min at 377C. The cellsment of the resultant adipocyte phenotype by oil red O staining
were then washed three times with PBS, mounted with ¯uorophorewas performed as previously described for these cells (Yamaguchi
and a coverslip, and photographed with a Zeiss Axioplan micro-and Kahn, 1991).
scope.
Northern Hybridization Analysis
Cells were cultured in growth media (20% fetal calf serum) or RESULTS
were switched to differentiation media for 3±5 days. RNA was
isolated (Chomczynski and Sacchi, 1987) and analyzed by Northern
blotting (Sambrook, 1989) using cDNA probes radiolabelled by ran- Expression of MyoD in Preosteoblasts and
dom priming (Boehringer Mannheim). Following hybridization at Osteoblasts
427C for 24 hr, the nylon ®lters (Genescreen, NEN research prod-
ucts) were washed in 0.51 SSC, 0.5% SDS for 20 min at 427C, and For our transfection studies, we used two cell lines, ROB
0.11 SSC, 0.5% SDS, twice for 30 min at 557C. cDNAs for myosin C20 and C26, which were concomitantly derived from the
light chain 2, MyoD (Davis et al., 1987), Id-1 (Benezra et al., 1990), same rat calvarial cell preparation (Yamaguchi and Kahn,
Id2 (Sun et al., 1991), Id3 (Christy et al., 1991), and myogenin
1991). Previous studies have shown that these cells differen-(Wright et al., 1989) were used as hybridization probes to assess
tially express osteoblastic markers, and thus may representinduction of myogenic differentiation.
different stages of osteoblastic differentiation. C20 cells ex-
press several features of the osteoblastic phenotype: high
levels of the osteoblastic form of alkaline phosphatase,Western Analysis
cAMP production in response to parathyroid hormone and
Equal quantities of protein (determined by the Bio-Rad colorimet- prostaglandin E2, and type I collagen synthesis (Yamaguchi
ric assay) were analyzed by electrophoresis in 12% (for troponin T, and Kahn, 1991). Because C20 cells express only this pheno-
myogenin, or MyoD) or 7.5% (for pRB or myosin heavy chain) type and no other, C20 cells are considered to represent
denaturing polyacrylamide gels and transferred to nitrocellulose
osteoblasts. In contrast, C26 cells express a much lowermembranes at 40 V for 2 hr. The blots were washed for 10 min in
level of alkaline phosphatase and are capable of expressingTBST (25 mM Tris, pH 8.0, 125 mM NaCl, 0.025% Tween 20),
alternate phenotypes. For example, C26, but not C20 cells,incubated in blocking buffer (25 mM Tris, pH 8.0, 125 mM NaCl,
can differentiate into adipocytes by treatment with dexa-0.1% Tween 20, 1% BSA, 0.1% NaN3) for 2 hr at room temperature
or 24 hr at 47C, and then incubated with the antibody for 2 hr at methasone (Yamaguchi and Kahn, 1991). Because C26 cells
room temperature. They were then washed three times with express low levels of some osteoblastic markers and can be
blocking buffer (15 min per wash) and incubated with a secondary, induced to form a mineralized matrix, C26 cells are consid-
alkaline phosphatase-conjugated antibody (Promega) for 1 hr. After ered to represent less-differentiated cells, i.e., ``preosteo-
three 15-min washes with blocking buffer and three 5-min washes blasts.''
with TBST, the membranes were incubated in phosphatase sub- C20 cells were transfected with an expression plasmid
strate (BCIP/NBT, Kirkegaard and Perry Laboratories) for 5±30 min
for the myogenic transcription factor MyoD under the con-and, once developed, washed with distilled water. Antibodies for
trol of the CMV promoter, and stable clones were estab-troponin T were provided by Dr. Charles Ordahl (University of
lished. Among the approximately 50 G418-resistant clones,California, San Francisco), and those for myosin heavy chain (i.e.,
only one expressed MyoD mRNA. This clone did not ex-MF20 antibody) were purchased from the Developmental Studies
Hybridoma Bank at NICHD. The antibodies to pRB (DeCaprio et press mRNA for myosin light chain 2 or myogenin, two
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3). Accordingly, C26Myo, but not C20Myo, expressed myo-
sin heavy chain and myogenin (Fig. 4). Uninfected C26 and
C20 cells did not form myo®bers (Fig. 3) nor did they express
muscle marker proteins under similar conditions (Fig. 4).
The MyoD protein in these nondifferentiating C20Myo
cells was functional because it could cooperate with E47
(introduced by transient transfection) to activate transcrip-
tion of an exogenous myosin light chain 1 enhancer/pro-
moter±chloramphenicol acetyltransferase (CAT) construct
(pMLC1CAT920; Rosenthal et al., 1989) (data not shown;
see below). Our results show that two closely related cell
lines, C20 and C26, derived from the same passage of paren-
tal cells, display different abilities to be converted to the
myogenic phenotype by forced expression of MyoD.
FIG. 1. Expression of muscle-speci®c mRNAs in MyoD-express- Dexamethasone Abolishes the Myogenic Phenotype
ing C20 osteoblasts. (A) Northern blot analysis of mRNA for myo- of MyoD-Expressing C26 Cells
sin light chain (MLC) or myogenin (Mgn). RNA was prepared from
Our results suggest that during maturation of multipoten-untransfected (0) or transfected, MyoD-expressing (M) C20 cells,
tial mesenchymal cells to fully differentiated osteoblasts,cultured in growth (0) or differentiation (/) medium for 3 days.
RNA from C2C12 myoblasts, cultured under the same conditions, cells undergo a change(s) which confers resistance to the
was included as a positive control. Equal amounts of RNA (5 mg) myogenic effects of MyoD. To further test the hypothesis
were analyzed. The myosin light chain and myogenin expression that differentiation along one pathway precludes progres-
in C2C12 myoblasts in growth medium (0) is due to spontaneous sion along another, we examined whether induction of C26
differentiation of a fraction of con¯uent cells, as previously de- cells to an alternate phenotype would block their ability to
scribed (Lassar et al., 1989; Filvaroff et al., 1993). (B) Western blot express a myogenic phenotype. Because C26 cells differenti-
analysis using antibodies to myosin heavy chain (MHC). Equal
ate into adipocytes in the presence of dexamethasone (Ya-quantities of protein from untransfected (0) or MyoD-expressing
maguchi and Kahn, 1991), both parental C26 and C26Myo(M) C20 osteoblasts grown under differentiation conditions were
cells were treated with dexamethasone and tested for ex-analyzed. Differentiated C2C12 myoblasts were included as posi-
pression of myogenic differentiation markers. As previouslytive control.
reported (Yamaguchi and Kahn, 1991) and con®rmed by oil
red O staining of fat droplets (data not shown), dexametha-
sone induced the formation of adipocytes in both C26 and
markers of muscle cell differentiation (Fig. 1), nor did these
cells fuse to form myotubes when cultured in differentia-
tion medium, i.e., low serum which normally induces myo-
blasts to form multinuclear myotubes (data not shown).
Because MyoD expression is known to inhibit cell growth
(Sorrentino et al., 1990; Crescenzi et al., 1990), MyoD-ex-
pressing cells are likely to be lost during selection of stable
clones, which may explain the low incidence of MyoD-
expressing stable clones.
We therefore infected cells with a recombinant retrovirus
that directs MyoD expression. We used a retroviral vector
with a high multiplicity of infection so that most cells
would contain the exogenous MyoD gene and analysis of FIG. 2. Expression of MyoD protein in MyoD-expressing cells.
Protein extracts were prepared from parental C20 osteoblasts orthese cells could be done within 1 week of infection. After
C26 preosteoblasts, or from cells infected with a MyoD-encodinginfection, C20 and C26 cells expressed MyoD mRNA (data
retrovirus (C20M and C26M), cultured in growth (0) or differentia-not shown) and MyoD protein (Fig. 2). These cells did not
tion (/) media. Each lane contains equal amounts of protein, whichexpress endogenous MyoD mRNA as assessed by Northern
were analyzed together by Western blotting using MyoD antibody.analysis (data not shown), even though forced expression
C2C12 myoblasts cultured under the same conditions were in-of a transfected MyoD gene activates endogenous MyoD
cluded as a positive control. The two sets of lanes for C26M and
expression in various cell lines (Lassar et al., 1989a; Thayer C20M correspond to two different pools of retrovirally infected
et al., 1989; Weintraub et al., 1989). In differentiation me- cells. In C20 and C20M cells, the antibody-reactive bands of higher
dium, C26 cells infected with the MyoD retrovirus, molecular weight than MyoD that are induced by differentiation
C26Myo, but not the corresponding C20 cells, C20Myo, medium are very unlikely to represent MyoD variants because C20
cells do not express MyoD mRNA.formed elongated, primarily mononucleated myo®bers (Fig.
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FIG. 3. Morphology of parental (0) and MyoD (Myo)-expressing C26 preosteoblasts and C20 osteoblasts. Cells were cultured in differentia-
tion medium for 3 days and then photographed by phase-contrast microscopy to document myotube formation.
C26Myo cells. Concurrently, dexamethasone inhibited the rally expressed MyoD gene. In agreement with previous
®ndings (Weintraub et al., 1989; Hu et al., 1995; Teboul etability of C26Myo cells to form elongated, predominantly
mononucleated, myo®bers (Fig. 5A) and to express myosin al., 1995), we conclude that the adipocyte and myoblast
phenotypes are mutually exclusive.heavy chain and troponin T (Fig. 5B). Thus, induction of an
adipocytic phenotype is associated with turning off expres-
sion of muscle-speci®c genes, even in cells with a retrovi-
Expression of pRB, Id, and MyoD in C20 Cells
The inability of C20Myo cells to exhibit a myogenic phe-
notype could be due to the absence of some factor required
for myoblast differentiation. For example, the osteosar-
coma-derived cell line, Saos-2, is unable to undergo MyoD-
induced myogenic differentiation due to expression of a
truncated, nonfunctional form of the retinoblastoma gene
product, pRB (Gu et al., 1993). We therefore tested whether
C20 cells expressed pRB protein. In a manner similar to
normal cycling myoblasts, C20 cells in growth media (10%
serum) expressed pRB in both its phosphorylated (upper
band) and hypophosphorylated (lower band) forms (Fig. 6A,
lane 2). Furthermore, C20 and C20Myo cells in differentia-
tion media (2% horse serum) expressed pRB in its hypophos-
phorylated form (Fig. 6A, right), which is known to bind to
MyoD (Gu et al., 1993).
The inability of C20Myo cells to undergo myogenic differ-
entiation could also be attributed to a high expression level
FIG. 4. Expression of muscle-speci®c proteins in parental or
of any one of the Id genes (Benezra et al., 1990; Christy etMyoD-expressing (M) C26 and C20 cells. Equal amounts of protein
al., 1991; Sun et al., 1991). By direct binding to E proteins,extracts of cells cultured in growth (0) or differentiation medium
Id proteins prevent the association of E proteins with MyoDwith 2% horse serum (H) or insulin (I) were analyzed by Western
and the transcriptional activity of MyoD, which results inblotting using antibodies for myosin heavy chain (MHC) or myo-
genin (Mgn). an inhibition of differentiation (Benezra et al., 1990). As
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FIG. 5. Phenotype of MyoD-expressing C26 preosteoblasts treated with dexamethasone. (A) Morphology of C26 cells cultured in the
absence (0) or presence of dexamethasone (Dex) for 9 days. Photography was carried out by phase-contrast microscopy. (B) Expression of
muscle-speci®c proteins. Protein extracts prepared from parental (0) or MyoD-expressing (Myo) cells, untreated (0) or cultured with
dexamethasone (D) for 9 days in growth medium, were analyzed by Western blot analysis for myosin heavy chain (MHC) or troponin T
(TnT) expression.
shown in Fig. 6B (left), C20 cells expressed Id1 mRNA at a sion protein were transfected into C20 cells, and stable
clones were tested for their ability to undergo myogeniclevel which was slightly higher than that of C26 cells, but
considerably lower than in the myoblast cell line C2C12, differentiation. C20 cells transfected with MyoD±E47, but
not those transfected with either MyoD or E47 alone (dataor in 10T1/2 cells, which can undergo MyoD-induced myo-
genic differentiation (Davis et al., 1987). In addition, the Id1 not shown), were able to form elongated ®bers which ex-
pressed myosin heavy chain protein as detected by bothlevels in C20 cells in differentiation medium are compara-
ble to or less than those in C2C12 myoblast cultures under immuno¯uorescence (Fig. 7A) and by Western analysis (Fig.
7B). Within the population of C20 cells transfected withthe same conditions (Fig. 6B, right) in which C2C12 cells
undergo myogenic differentiation (Blau et al., 1983; Lassar MyoD alone, a few rounded, mononuclear cells occasionally
stained weakly positive for myosin heavy chain (MHC) byet al., 1989a). Id2 and Id3 mRNA levels were similar in
C20 and C26 cells and were not signi®cantly affected by immuno¯uorescence. However, the incidence of MHC-pos-
itive cells was considerably lower than that found in C20expression of MyoD in these two cell lines (Fig. 6C). Finally,
localization of MyoD protein in the cytoplasm rather than cells transfected with tethered MyoD±E47 as re¯ected by
Western analysis of this protein (Fig. 7B). In addition, tran-the nucleus is an additional way to inhibit MyoD-induced
myogenesis (Rupp et al., 1994). Therefore, we con®rmed by sient transfections of C20 cells with MyoD and E47, either
as separate proteins (trans) or as the tethered hybrid (cis), ledimmuno¯uorescence that the MyoD protein was present in
the nucleus of C20 cells (data not shown). Thus, neither to transcriptional activation of a muscle-speci®c promoter
assessed using a chloramphenicol acetyltransferase reporterthe absence of pRB nor high levels of Id1, 2, or 3 expression
nor mislocalization of MyoD can explain the resistance of assay (Rosenthal et al., 1989) (data not shown). Thus, in the
presence of high levels of E proteins (in cis or in trans),C20 cells to MyoD-induced myogenic conversion.
MyoD was able to convert C20 cells to a myogenic pheno-
type, suggesting that these cells contain all factors neces-
Expression of a Tethered MyoD±E47 Fusion sary for induction of myogenesis by the MyoD±E47 com-
Protein Induces Myogenic Conversion plex.
The inability of C20Myo cells to differentiate could be
due either to the presence of an inhibitor of MyoD activity MyoD Expression in Precartilage
or to the absence of a positive factor required for MyoD and Cartilage Cells
activity. To distinguish between these two possibilities, we
utilized a MyoD±E47 hybrid protein, in which MyoD is As shown above, the progression from a multipotential
cell capable of becoming an osteoblast to a cell expressingtethered to a transcriptional partner E47 (Neuhold and
Wold, 1993). Because this hybrid protein can activate mus- several osteoblastic markers, as represented by the C26 and
C20 cell lines, respectively, is accompanied by a loss ofcle-speci®c genes even in the presence of inhibitory pro-
teins, the MyoD±E47 protein is considered to act as a domi- ability to be converted to a myogenic phenotype by MyoD.
To test whether this phenomenon occurs during differentia-nant positive form of MyoD (Neuhold and Wold, 1993).
Expression plasmids for MyoD, E47, or the MyoD±E47 fu- tion of other types of mesenchymal cells, we used another
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tial and can express collagen X, which is speci®cally found
in hypertrophic cartilage, this cell line is likely to represent
a more mature chondrocyte. Thus, similarly to the osteo-
blastic C26 and C20 cells, the C12 and C5.18 cells may
represent two closely related stages of chondrocytic matura-
tion, with C12 cells being less mature than C5.18 cells.
The C12 and C5.18 cells were infected with the MyoD-
expressing retrovirus and were evaluated for their ability
to express a myogenic phenotype. Infected C12Myo and
C5.18Myo cells expressed MyoD protein as assessed by
Western blotting (Fig. 8A). However, only C12Myo cells,
but not C5.18Myo cells, formed spindle-shaped, predomi-
nantly mononuclear, ®bers (Fig. 8B) and expressed myosin
heavy chain, myogenin (Fig. 9) and troponin T (data not
shown) when cultured in differentiation medium. Thus, the
ability of MyoD to induce myogenesis in C12 cells, but not
in C5.18 cells, correlates with their degree of differentiation
within the chondrocytic lineage. These results are similar
to those seen with the two ROB subclones, C26 and C20,
where only the less-differentiated cells were converted to
a myogenic phenotype by MyoD. Furthermore, as in C20
osteoblasts, transient transfection of C5.18 chondrocytes
with the dominant positive form of MyoD (tethered to E47)
activated transcription from the myosin light chain 1 pro-
moter (data not shown), suggesting that RCJ5.18 have all
factors necessary for activation of muscle-speci®c genes by
the MyoD±E47 complex.FIG. 6. Expression of the retinoblastoma protein pRB and Id
We then tested whether altering the differentiation statemRNA in parental and MyoD-expressing C20 and C26 cells. (A)
of RCJ3.1 cells with dexamethasone would affect their abil-Detection of pRB by Western blot analysis of protein extracts pre-
pared from proliferating C2C12 myoblasts (1) or C20 osteoblasts ity to be converted by MyoD. Dexamethasone induces
(2). In addition, protein extracts were prepared from parental or
MyoD-expressing (M) C20 cells, cultured in growth (0) or differen-
tiation (/) medium for 3 days. To allow myotube formation, cells
were grown to maximal con¯uence, which may explain the relative
abundance of hypophosphorylated pRB (the fastest moving pRB
band) in cells in growth medium. (B) Detection of Id. mRNA by
Northern hybridization in C2C12 myoblasts, C20 osteoblasts, C26
preosteoblasts, and 10T1/2 ®broblasts (10T) cultured in growth me-
dium (left). In a separate experiment (right), RNA was prepared
from C20 osteoblasts, C26 preosteoblasts, and C2C12 myoblasts
cultured in growth medium (0) or differentiation medium with 2%
horse serum (H) or insulin (I). Equal amounts (15 mg) of RNA were
analyzed. (C) Detection of Id2 and Id3 mRNA by Northern hybrid-
ization in C20 osteoblasts (C20) or C26 cells (C26) parental (0) or
the corresponding cells expressing MyoD (M).
matched pair of cell lines, the subclones C5.18 and C12,
derived from the multipotential cell line RCJ3.1 (Grigori-
adis et al., 1988, 1990). C5.18 cells differentiate into chon-
FIG. 7. Conversion of C20 osteoblasts to a myogenic phenotypedrocytes spontaneously when cultured at high plating den-
by expression of the dominant positive MyoD-E47 protein. (A) C20sity, or in the presence of dexamethasone at lower density.
cells expressing either MyoD alone (M) or the MyoD-E47 fusionIn contrast, C12 cells do not differentiate into chondrocytes
(ME) were stained by immuno¯uorescence using antibodies to my-
either spontaneously or in the presence of dexamethasone, osin heavy chain. (B) Western blot detection of myosin heavy chain
but can be induced to form cartilage nodules by BMP-2 (MHC) in protein extracts of C20 cells expressing MyoD alone (M)
(50 ng/ml) at low plating density (Aubin et al., personal or MyoD tethered to E47 (ME), cultured in growth medium (0) or
communication). For this reason, C12 cells will be referred differentiation medium containing 2% horse serum (H) or insulin
(I) for 3 days.to as ``prechondrocytes.'' Because C5.18 cells are unipoten-
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prisingly, treatment of C5.18Myo with dexamethasone and
insulin, but not either agent alone, induced expression of
myogenin (Fig. 9) and troponin T (data not shown) in these
cells. Based on this result, we examined the effect of insulin
and dexamethasone on the expression of the chondrocytic
phenotype. Unlike dexamethasone alone, dexamethasone
and insulin did not induce expression of type II collagen
in C5.18 cells (Fig. 10). These results suggest that insulin
inhibits dexamethasone induction of chondrocytic differen-
tiation, which may thus facilitate myogenic differentiation
of C5.18Myo cells. Our results support the idea that myo-
genic differentiation and other types of mesenchymal cell
differentiation, such as chondrocytic, are mutually exclu-
sive, and agree with previous ®ndings that myogenic and
chondrocytic markers are not expressed in the same cells
(Choi et al., 1990).
DISCUSSION
Our results show that less-differentiated osteoblasts and
chondrocytes, but not their more mature counterparts, can
be converted to a myogenic phenotype by expression of an
exogenous MyoD gene. However, osteoblasts can be in-
duced to express muscle-speci®c proteins by transfection
with MyoD in its dominant positive form, i.e., tethered to
E47 (MyoD±E47). The MyoD-induced conversion of the
less-differentiated mesenchymal cells is consistent with
previous observations that MyoD can induce expression of
muscle-speci®c proteins in most, but not all, cell types
FIG. 8. Expression of MyoD protein in RCJ3.1 cells infected with (Davis et al., 1987; Schafer et al., 1990; Weintraub et al.,
a recombinant retrovirus, and its effect on morphology. (A) Western 1989; reviewed in Olson, 1990, and Weintraub et al., 1991;
blot detection of MyoD in parental (0) or infected, MyoD-express- Olson and Klein, 1994).
ing (M) C12 prechondrocytes and C5.18 chondrocytes, cultured in The inability of MyoD-expressing osteoblasts to undergo
growth medium (0) or differentiation medium containing 2% horse
myogenic differentiation after introduction of an exogenousserum (H) or insulin (I). Equal amounts of protein extract were
analyzed. The identity of the lower bands in the C12M and C5.18M
cells is unknown, but they may represent degradation products. (B)
C12 prechondrocytes (C12M) or C5.18 chondrocytes infected with
a MyoD-encoding retrovirus were cultured in differentiation me-
dium containing insulin for 3 days and photographed by phase-
contrast microscopy.
chondrocytic differentiation of a number of pluripotential
or prechondrocytic cell lines (Grigoriadis et al., 1988, 1990).
In the less-differentiated C12 cells, dexamethasone does not
induce chondrocytic differentiation (Aubin et al., personal
communication) and did not affect the ability of C12Myo
FIG. 9. Expression of myosin heavy chain and myogenin in C12cells to express myoblast markers (Fig. 9). In contrast, dexa-
prechondrocytes and C5.18 chondrocytes. Parental (0) and MyoD-methasone induces chondrocytic differentiation of C5.18
expressing (Myo) C12 and C5.18 cells were cultured in growth (0)cells (Aubin et al., personal communication) as shown by
or differentiation medium containing either 2% horse serum (H)
expression of type II collagen, a cartilage-speci®c marker or insulin (I) for 3 days, in the absence (0) or presence (Dex) of
(Fig. 10). This induction did not occur in C5.18Myo cells dexamethasone. Equal amounts of protein were analyzed by West-
(Fig. 10), suggesting that MyoD inhibited at least one aspect ern blotting using antibodies to myosin heavy chain (MHC) or myo-
of the chondrocytic phenotype of these cells even though genin (Mgn). C2C12 myoblasts cultured under similar conditions
were included as a positive control.MyoD did not induce myogenic differentiation (Fig. 9). Sur-
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FIG. 10. Immuno¯uorescent detection of collagen II expression in C5.18 chondrocytes, cultured in growth medium (0) with dexametha-
sone (Dex) or dexamethasone and insulin (Dex / ITS), or in MyoD-expressing C5.18 cells treated with dexamethasone (Myo Dex).
MyoD gene is consistent with some studies on osteosar- variable degree of myogenic conversion and coincident loss
of the chondrocytic phenotype (Choi et al., 1990). However,coma cell lines. Saos-2 cells, but not U20S cells, are resis-
tant to the effects of MyoD alone (Gu et al., 1993). TE85 in the control cultures, not all cells stained positive for early
cartilage markers (Choi et al., 1990), suggesting that thiscells require both MyoD expression and treatment with the
demethylating agent 5-azacytidine in order to undergo sig- heterogeneous pool of cells may contain less-differentiated
cells which are susceptible to conversion. These cell cul-ni®cant myogenic conversion (Chen and Jones, 1990). Thus,
expression of genes other than MyoD must be altered in tures may thus be comparable to our MyoD-sensitive
RCJ3.1 C12 prechondrocyte line, rather than the MyoD-order to induce a myogenic phenotype in osteoblasts. In
their study, myosin heavy chain-expressing cells continued resistant RCJ3.1 C5.18 chondrocyte line which can express
collagen X, a late marker of chondrocyte differentiation.to stain positive for alkaline phosphatase (Chen and Jones,
1990), a stable enzyme expressed in osteoblasts and other To evaluate the possible mechanistic basis of resistance
of osteoblasts and chondrocytes to the differentiating effectscell types (Nair et al., 1987). The different responses of these
osteosarcoma cell lines to MyoD may be related to their of MyoD alone, one must consider how MyoD normally
functions. To act as an ef®cient transcriptional activator ofdegree of differentiation because it has been suggested that
tumor cells continue to express the phenotype apparent at muscle-speci®c genes, the MyoD protein must associate
with one of the ubiquitous E proteins, such as E47 or E12.the time of transformation (Greaves et al., 1986). In contrast
to our C20 cells, all osteosarcoma cell lines were derived The MyoD-E protein complexes bind to de®ned E box se-
quences upstream of muscle-speci®c genes and activatefrom tumors for which the genetic lesion is unknown, and
which may have uncoupled the processes of differentiation their transcription. The interaction between MyoD and E47
is required for several reasons. Not only does this hetero-and proliferation. Therefore, these cells may not be truly
representative of normal osteoblasts. merization considerably enhance the DNA binding ef®-
ciency of MyoD compared to MyoD alone (Murre et al.,Our data also show that MyoD can convert prechondro-
cytes, but not chondrocytes to a myogenic phenotype. Previ- 1989b; Sun and Baltimore, 1991), but it also changes the
DNA sequence binding speci®city (Blackwell and Wein-ous studies have shown that introduction of the MyoD gene
into primary chicken chondroblasts results in a low and traub, 1990). Furthermore, association with E proteins alters
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the phosphorylation state of MyoD and creates a more ef®- with MyoD for association with E proteins, such a bHLH
protein could block the effect of MyoD alone but not thatcient transcriptional activator than the MyoD homodimer
(Lassar et al., 1991; Bengal et al., 1994). MyoD activity can of either a tethered MyoD±E47 protein or high levels of
both of these proteins in trans.be regulated at each of these steps, and these individual
events can be dissociated from each other. Accordingly, re- Several other lines of evidence suggest the involvement
of bHLH proteins in osteoblast differentiation. First, levelssistance to the myogenic activity of MyoD could be attrib-
uted to inhibition of any of these steps. However, in the case of Id mRNA decrease during osteoblast differentiation
(Ogata and Noda, 1991; Kawaguchi et al., 1992; Murray etof C20 osteoblasts, a mechanistic basis for the resistance to
myogenic conversion by MyoD is suggested by our ®nding al., 1992) and downregulation of Id is required for osteoblas-
tic differentiation (Murray et al., 1992). Second, many genesthat MyoD in combination with E47 separately (in trans)
or tethered to MyoD (in cis) is able to induce myogenic expressed in osteoblasts, including the osteoblast-speci®c
osteocalcin gene, contain E-boxes to which bHLH proteinsdifferentiation. Indeed, these results suggest that an inabil-
ity of endogenous E47 to associate with MyoD may be the can bind (Siddhanti and Quarles, 1994). Finally, E-box bind-
ing activity increases during osteoblastic differentiationlimiting step in the myogenic conversion of C20 osteo-
blasts. In fact, transient transfection of C20Myo cells with (Kawaguchi et al., 1992). Thus, our results using the domi-
nant positive MyoD further support the hypothesis thatan E47 expression plasmid results in activation of a muscle-
speci®c promoter/enhancer±CAT construct. Furthermore, expression of a bHLH protein is induced during osteoblastic
differentiation. Expression of such a protein could explainonce the association of E47 and MyoD is favored by high
levels of both proteins in trans, or in cis as a tethered the apparent mutual exclusivity of myogenic and osteoblas-
tic differentiation.MyoD±E47 fusion protein, C20 cells have all factors re-
quired for induction of myogenesis by the MyoD±E47 com- Whereas expression of a bHLH protein which competes
with MyoD for E protein binding may best explain the in-plex.
The resistance of C20 osteoblasts to myogenic conversion ability of MyoD to convert C20 osteoblasts into myoblasts,
we cannot exclude the possibility of other inhibitory mech-by MyoD alone and the dominant positive effect of MyoD
and E47 in combination could in principle be attributed anisms. Many proteins have been shown to affect MyoD
activity. For example, c-jun and junB can associate withto low endogenous levels of E proteins. This possibility is
unlikely since expression of E47/E12 is found in all cell MyoD and thereby inhibit its activity (Bengal et al., 1992;
Li et al., 1992), and high expression of c-myc (Miner andlines tested (Murre et al., 1989a; Zhuang et al., 1992; Len-
ardo et al., 1987), and is not altered during osteoblastic dif- Wold, 1991) or c-fos (Lassar et al., 1989a; Li et al., 1992a)
has been shown to inhibit myogenic differentiation. Inhibi-ferentiation (Murray et al., 1992). In addition, E47/E12 pro-
teins are only two members of a family of E proteins which tion of MyoD-induced myogenesis in osteoblasts could also
be explained by expression of the homeobox proteins Msx1can bind to bHLH proteins and activate transcription, and
may be functionally redundant in cultured cells (for review, and Msx2, which play key roles in skeletal bone develop-
ment (Jabs et al., 1993; Satokata and Maas, 1994) and cansee Kadesch, 1992). Moreover, antisense experiments sug-
gest that E47/E12 expression is not essential for differentia- inhibit myogenesis (Song et al., 1992; Woloshin et al., 1995)
by blocking expression of MyoD (Woloshin et al., 1995).tion of embryonic stem cells into skeletal and cardiac mus-
cle, erythrocytes, neurons, and cartilage (Zhuang et al., Expression of these proteins in C20 and C26 cells may ex-
plain the absence of autoinduction of the endogenous MyoD1992). Thus, in the absence of E47/E12, perhaps other mem-
bers of the E protein family might functionally substitute. gene (Thayer et al., 1989) observed in these cells (data not
shown). Finally, MyoD is extensively phosphorylated (Taps-A more likely explanation, however, for the requirement
of a tethered MyoD-E47 protein to induce conversion of cott et al., 1988), and phosphorylation at speci®c sites can
alter its activity (Li et al., 1992b). Clearly the regulation ofC20 cells, is that these cells express a factor which interferes
with association of MyoD and E proteins. Based on the dif- MyoD activity is complex, as MyoD can interact with many
possible partners and can also be posttranslationally modi-ferential myogenic effect of MyoD on C26 and C20 cells,
the expression or activity of such a factor is likely to be ®ed in multiple ways.
The study of cells resistant to the myogenic effects ofinduced upon transition from multipotential cell to osteo-
blast. Several proteins have previously been shown to inter- MyoD has already proven useful in identifying proteins re-
quired for myogenesis (Gu et al., 1993). Considering thefere with E47±MyoD association and subsequent myogenic
conversion. The best studied inhibitors of myoblast differ- mutual exclusivity of myogenic and adipocytic (Weintraub
et al., 1989, Hu et al., 1995; Teboul et al., 1995), osteoblasticentiation are the Id proteins (Benezra et al., 1990; Christy
et al., 1991; Sun et al., 1991) which directly compete with (Yamaguchi et al., 1991; Katagiri et al., 1994), or chondro-
cytic (Choi et al., 1990) phenotypes, the proteins involvedMyoD for association with E proteins (Jen et al., 1992). We
have shown that expression of Id1, 2, and 3 is not signi®- in induction of adipocytic, osteoblastic, or chondrocytic dif-
ferentiation may also be involved in resistance of more ma-cantly higher in osteoblasts than in their less-differentiated
counterparts, which raises the possibility of another bHLH ture cells in these lineages to myogenic conversion. Thus,
the study of two pairs of matched cell lines with differentialprotein which binds to and complexes with E47 in C20
osteoblasts but not in the progenitor cells. By competing sensitivities to the myogenic activity of MyoD, and repre-
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blasts, chondroblasts, smooth muscle, and retinal pigmented epi-senting different stages of osteoblastic or chondrocytic mat-
thelial cells into striated mononucleated myoblasts and multinu-uration, may help us to better understand the process of
cleated myotubes. Proc. Natl. Acad. Sci. USA 87, 7988±7992.myogenic conversion. Comparative studies of these pairs of
Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNAcell lines may also allow the identi®cation of proteinsÐ
isolation by acid guanidium thiocyanate±phenol±chloroform ex-possibly bHLH proteinsÐwhich play a role in the commit-
traction. Anal. Biochem. 162, 156±159.
ment and differentiation of cells within the osteoblastic or Christy, B. A., Sanders, L. K., Lau, L. F., Copeland, N. G., Jenkins,
chondrocytic lineage. N. A., and Nathans, D. (1991). An Id-related helix-loop-helix pro-
tein encoded by a growth factor-inducible gene. Proc. Natl. Acad.
Sci. USA 88, 1815±1819.
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